A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2015
At a glance
- Drugs Calcium supplements; Parathyroid hormone
- Indications Menopause; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms CAP
- Sponsors NPS Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 12 Aug 2008 Actual end date added (Apr 2005) as reported by ClinicalTrials.gov.
- 12 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.